Killer Cells, Lymphokine-Activated
Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients.
Year introduced: 1990
PubMed search builder options
Subheadings:
Tree Number(s): A11.118.637.555.283.500, A11.118.637.555.567.537.500, A15.145.229.637.555.283.500, A15.145.229.637.555.567.537.500, A15.382.490.555.283.500, A15.382.490.555.567.537.500
MeSH Unique ID: D015979
Entry Terms:
- Cell, Lymphokine-Activated Killer
- Cells, Lymphokine-Activated Killer
- Killer Cell, Lymphokine-Activated
- Killer Cells, Lymphokine Activated
- Lymphokine-Activated Killer Cell
- Lymphokine-Activated Killer Cells
- Lymphokine Activated Killer Cells
- LAK Cells
- Cell, LAK
- Cells, LAK
- LAK Cell
Previous Indexing:
See Also: